10x Genomics, Inc.
TXG
$20.92
$0.422.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.47M | -16.25M | -27.47M | 34.54M | -34.36M |
| Total Depreciation and Amortization | 9.96M | 12.10M | 12.25M | 9.65M | 8.02M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.35M | 26.35M | 26.67M | 27.21M | 32.41M |
| Change in Net Operating Assets | 5.29M | 18.58M | 31.77M | -53.69M | 28.28M |
| Cash from Operations | 26.12M | 40.78M | 43.21M | 17.71M | 34.35M |
| Capital Expenditure | -1.60M | -1.78M | -687.00K | -1.58M | -1.89M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -652.00K | -8.62M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 286.00K | 624.00K | 502.00K | 639.00K | -- |
| Cash from Investing | -1.31M | -1.81M | -8.80M | -939.00K | -1.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 273.00K | 2.24M | 617.00K | 3.52M | 422.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.69M | -- | -- | -- | -- |
| Cash from Financing | -8.42M | 2.24M | 617.00K | 3.52M | 422.00K |
| Foreign Exchange rate Adjustments | -73.00K | 43.00K | -33.00K | 360.00K | 114.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.32M | 41.26M | 35.00M | 20.65M | 32.99M |